Press Release

Morgan Lewis Represents MEI Pharma in $75M Private Placement Sale of Common Stock

May 15, 2018

NEW YORK, May 15, 2018: Morgan Lewis advised oncology company MEI Pharma, Inc. in its $75 million private placement sale of common stock. The transaction was announced on May 14 and is subject to customary closing conditions.

The Morgan Lewis team was led by partners Steven Navarro and Finn Murphy. Associates Jeff Letalien and Elizabeth Lee provided support.

For more details, read the announcement by MEI Pharma.